{
  "url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010/schedule/paragraph-15",
  "json_url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010/schedule/paragraph-15.json",
  "legislation": "uksi/2010/1614",
  "legislation_title": "The General Pharmaceutical Council (Appeals Committee Rules) Order of Council 2010",
  "legislation_url": "https://openlegislation.uk/general-pharmaceutical-council-appeals-committee-rules-order-of-council-2010",
  "path": "schedule/paragraph/15",
  "kind": "paragraph",
  "number": "15",
  "heading": "Vulnerable witnesses at hearings",
  "text": "(1) In proceedings before the Committee, the following may, if the quality of their evidence is otherwise likely to be adversely affected, be treated as vulnerable witnesses—\n(a) any witness under the age of 18;\n(b) any witness with a mental disorder (within the meaning of the Mental Health Act 1983);\n(c) any witness who is significantly impaired in relation to intelligence or social functioning;\n(d) any witness with a physical disability who requires assistance to give evidence;\n(e) any witness, where an allegation against any person is of a sexual nature and the witness was the alleged victim; or\n(f) any witness who complains of intimidation.\n(2) Upon hearing representations from the parties the Committee may adopt such measures as it considers necessary to enable it to receive evidence from a vulnerable witness.\n(3) Measures adopted by the Committee may include, but are not to be limited to—\n(a) use of video links;\n(b) subject to paragraph (4), use of pre-recorded evidence as the evidence-in-chief of a witness, provided always that the witness is present at the hearing for cross-examination and questioning; and\n(c) use of interpreters (including signers and translators).\n(4) Where—\n(a) there is an allegation against any person of a sexual nature;\n(b) a witness is the alleged victim; and\n(c) the person against whom the allegation is made is not represented,\nthat person is not to be allowed to cross-examine the witness directly in person.\n(5) In the circumstances set out in paragraph (4), any questioning of the witness is to be undertaken by such person as the Committee considers appropriate.",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. rule 15 in force at 27.9.2010, see rule 1"
    },
    {
      "type": "footnote",
      "label": "f1",
      "text": "1983 c.20. “Mental disorder” is defined in section 1(2) as any disorder or disability of the mind."
    }
  ],
  "outstanding_effects": [
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    },
    {
      "type": "expiry of affecting provision Sch. rule 2",
      "affecting": "uksi/2021/26",
      "affecting_title": "The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2010/1614/schedule/paragraph/15",
    "retrieved_at": "2026-10-29T02:38:45.129905+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}